Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

It is described the case of a 74-years-old woman with probable Alzheimer Disease who showed good clinical response to rivastigmine associated with relevant improvement of cerebral perfusion after 1 year of treatment. The single-photon emission computed tomography (SPECT) scan showed a significant improvement in cortical uptake of the tracer in temporo-parietal and frontal regions in comparison to the examination performed before the treatment.

Original publication

DOI

10.1708/2002.21650

Type

Journal article

Journal

Riv Psichiatr

Publication Date

07/2015

Volume

50

Pages

188 - 191

Keywords

Aged, Alzheimer Disease, Brain, Cerebrovascular Circulation, Cholinesterase Inhibitors, Female, Humans, Predictive Value of Tests, Rivastigmine, Sensitivity and Specificity, Tomography, Emission-Computed, Single-Photon, Treatment Outcome